RIPCORD 2 Accepted for Presentation at European Society of Cardiology 2021

2021-07-06T14:25:26+00:00

RIPCORD 2 Accepted for Presentation at European Society of Cardiology 2021 AIMES has supported the success of the RIPCORD 2 multicentre clinical trial through the provision of the Streamline cloud-based trial management system for governance and oversight. The trial also used the REDCap electronic case record form platform at [...]